stella

The latest research,explained.

New treatments and completed trials across every condition — what was tested, what was found, and what it means for patients.

Recently completed trialsSee all results →
PTSDAugust 2026

New Therapy Helps Veterans With PTSD From Combat Killing Improve Faster

Veterans with PTSD from killing in combat improved their daily functioning—work, relationships, and home life—when treated with Impact of Killing (IOK), a specialized therapy. Those receiving IOK showed greater gains than veterans in standard therapy, and also reported better improvements in PTSD and moral injury symptoms.

What this means for patients

If you're a veteran struggling with PTSD or moral distress from combat killing, this therapy targets the specific trauma of that experience and may help you rebuild your life and relationships faster than other treatments. Ask the VA about IOK availability at your local medical center.

Read the full summary →
Atopic dermatitisAugust 2026

A JAK Inhibitor Cream Cleared Hand Eczema in 64% of Teens Who Used It

Researchers tested delgocitinib cream in 98 adolescents with moderate to severe hand eczema. After 16 weeks, 64% of teens using the cream had clear or almost clear skin, compared to 29% using a placebo cream. The treatment was well tolerated with no serious side effects.

Read →
Parkinson's diseaseAugust 2026

A Daily Pill Gave Early Parkinson's Patients 9 More Points of Movement Improvement

Researchers tested tavapadon, a once-daily pill, in 304 people with early Parkinson's disease. After 26 weeks, those taking tavapadon had significantly better movement and daily function scores compared to those on a sugar pill, with side effects mainly including nausea, headache, and dizziness.

Read →
Sickle cell diseaseJuly 2026

Virtual Mind-Body Program Helped 82% of Teens With Sickle Cell Pain

Researchers tested an 8-week online program combining talk therapy and gentle exercise for teens with ongoing sickle cell pain. Over 4 in 5 teens reported less pain after completing the program, and the improvement lasted at least 3 months.

Read →
Crohn's diseaseJuly 2026

A Surgery Recovery Program Cut Hospital Stays by a Day for Kids with Bowel Disease

Kids who got at least 13 of the program's 21 steps — things like earlier eating, less pain medicine, and faster movement after surgery — went home more than a day sooner and had half as many complications. The study tracked 597 children ages 10 to 18, most with inflammatory bowel disease, across 18 hospitals.

Read →
AnxietyJuly 2026

Mobile Mental Health App Reduced Anxiety in Breast Cancer Survivors More Than Education Alone

Breast cancer survivors using a suite of five mental health apps saw greater reductions in anxiety symptoms than those using an educational app alone over 12 months. Adding human coaching helped survivors who initially struggled to engage with the apps stay with the treatment longer.

Read →
SchizophreniaJuly 2026

New Antipsychotic LB-102 Reduced Acute Schizophrenia Symptoms More Than Placebo

In a 4-week trial of 359 adults hospitalized for acute schizophrenia, two doses of LB-102 significantly improved psychotic symptoms compared to placebo. The 50 mg and 75 mg doses showed the strongest effects, with side effects occurring in about half to two-thirds of patients across all groups.

Read →